New antibody joins fight against tough lung cancers
NCT ID NCT07246863
Summary
This study is testing whether adding a new antibody drug called visugromab to standard treatments helps control advanced non-small cell lung cancer that has worsened after initial therapy. It will compare different combinations of visugromab, an immunotherapy drug (nivolumab), and chemotherapy (docetaxel) against chemotherapy alone. The main goal is to see if these combinations shrink tumors and extend life for people who have already tried one prior treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital Saint Gallen, Clinic of Oncology and Hematology
RECRUITINGSankt Gallen, CH-9007, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke University Medical Center
NOT_YET_RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital of Jaen
RECRUITINGJaén, Andalusia, 23007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center)
NOT_YET_RECRUITINGBirmingham, Alabama, 35294-3300, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.